Sadaaki Maeda

1.3k total citations
59 papers, 1.1k citations indexed

About

Sadaaki Maeda is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Sadaaki Maeda has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 16 papers in Physiology. Recurrent topics in Sadaaki Maeda's work include Neuropeptides and Animal Physiology (14 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (10 papers). Sadaaki Maeda is often cited by papers focused on Neuropeptides and Animal Physiology (14 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (10 papers). Sadaaki Maeda collaborates with scholars based in Japan, United States and Taiwan. Sadaaki Maeda's co-authors include Akiko Yamamuro, Yasuhiro Yoshioka, Yuki Ishimaru, Atsushi Kasai, Reizo Inoki, Makio Saeki, Yoshinori Kamisaki, Norihito Shintani, Kiyokazu Ogita and Kihachi Saito and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Sadaaki Maeda

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sadaaki Maeda Japan 20 526 467 258 209 190 59 1.1k
Felipe Serrano Chile 20 645 1.2× 277 0.6× 209 0.8× 128 0.6× 396 2.1× 29 1.6k
Edward Leung Italy 24 1.0k 1.9× 379 0.8× 225 0.9× 146 0.7× 156 0.8× 52 2.2k
Tracey Hand United States 20 658 1.3× 350 0.7× 426 1.7× 97 0.5× 464 2.4× 30 1.9k
Daniel W. Gil United States 22 865 1.6× 372 0.8× 238 0.9× 81 0.4× 194 1.0× 29 1.5k
Margaret M. Zaleska United States 19 570 1.1× 344 0.7× 104 0.4× 98 0.5× 329 1.7× 39 1.4k
Masahiko Sugimoto Japan 25 817 1.6× 439 0.9× 121 0.5× 80 0.4× 331 1.7× 100 2.2k
Hiromichi Takano Japan 16 795 1.5× 319 0.7× 169 0.7× 95 0.5× 804 4.2× 43 1.6k
Jameel Dennis United States 14 455 0.9× 212 0.5× 295 1.1× 50 0.2× 227 1.2× 16 1.0k
Christopher J. Yuskaitis United States 16 914 1.7× 309 0.7× 98 0.4× 77 0.4× 210 1.1× 31 1.7k
Yuan Kang United States 23 756 1.4× 324 0.7× 117 0.5× 66 0.3× 147 0.8× 57 1.8k

Countries citing papers authored by Sadaaki Maeda

Since Specialization
Citations

This map shows the geographic impact of Sadaaki Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadaaki Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadaaki Maeda more than expected).

Fields of papers citing papers by Sadaaki Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadaaki Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadaaki Maeda. The network helps show where Sadaaki Maeda may publish in the future.

Co-authorship network of co-authors of Sadaaki Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Sadaaki Maeda. A scholar is included among the top collaborators of Sadaaki Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadaaki Maeda. Sadaaki Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawada, Koichi, Megumi Nishio, Yuka Watanabe, et al.. (2025). l-Theanine Uptake via Solute Carrier Family 38 Member 1 Inhibits Neuroblastoma Cell Growth. Neurochemical Research. 51(1). 17–17.
2.
Ishimaru, Yuki, et al.. (2020). Systemic Administration of an Apelin Receptor Agonist Prevents NMDA-Induced Loss of Retinal Neuronal Cells in Mice. Neurochemical Research. 45(4). 752–759. 12 indexed citations
4.
Ishimaru, Yuki, et al.. (2017). An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice. Scientific Reports. 7(1). 15062–15062. 31 indexed citations
5.
Ishimaru, Yuki, et al.. (2016). Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice. Journal of Pharmacological Sciences. 133(1). 34–41. 52 indexed citations
6.
Yoshioka, Yasuhiro, et al.. (2015). Dopamine inhibits lipopolysaccharide-induced nitric oxide production through the formation of dopamine quinone in murine microglia BV-2 cells. Journal of Pharmacological Sciences. 130(2). 51–59. 17 indexed citations
7.
8.
Kasai, Atsushi, Yuki Ishimaru, Yasuhiro Yoshioka, et al.. (2011). Apelin Deficiency Accelerates the Progression of Amyotrophic Lateral Sclerosis. PLoS ONE. 6(8). e23968–e23968. 53 indexed citations
9.
Yoshioka, Yasuhiro, et al.. (2006). Nitric Oxide Protects Macrophages from Hydrogen Peroxide-Induced Apoptosis by Inducing the Formation of Catalase. The Journal of Immunology. 176(8). 4675–4681. 47 indexed citations
10.
Yamamuro, Akiko, Yasuhiro Yoshioka, Kiyokazu Ogita, & Sadaaki Maeda. (2006). Involvement of Endoplasmic Reticulum Stress on the Cell Death Induced by 6-Hydroxydopamine in Human Neuroblastoma SH-SY5Y Cells. Neurochemical Research. 31(5). 657–664. 62 indexed citations
11.
Goto, Nobuyuki, Yuichiro Kayano, Ryoichi Yano, et al.. (2005). Clinical Evaluation of Early Post-Marketing Phase Vigilance-Features of Adverse Events Noted in Early Post-marketing Phase Vigilance-. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(8). 632–637.
12.
Osakada, Masakazu, Yukio Ago, Yutaka Kōyama, et al.. (2005). SEA0400, a specific inhibitor of the Na+–Ca2+ exchanger, attenuates sodium nitroprusside‐induced apoptosis in cultured rat microglia. British Journal of Pharmacology. 144(5). 669–679. 21 indexed citations
13.
Saeki, Makio, Sadaaki Maeda, & Yoshinori Kamisaki. (2002). Vanadate protects human neuroblastoma SH‐SY5Y cells against peroxynitrite‐induced cell death. Journal of Cellular Biochemistry. 85(4). 721–727. 4 indexed citations
14.
Saeki, Makio, Sadaaki Maeda, Kouichirou Wada, & Yoshinori Kamisaki. (2002). Insulin‐like growth factor‐1 protects peroxynitrite‐induced cell death by preventing cytochromec‐induced caspase‐3 activation. Journal of Cellular Biochemistry. 84(4). 708–716. 30 indexed citations
15.
Miwa, Yoshihiro, et al.. (1997). Effects of K+ channel blockers and K+ ionophore on isoprenaline-induced secretion of amylase from rat parotid acini. European Journal of Pharmacology. 322(1). 21–25. 2 indexed citations
16.
Miwa, Yoshihiro, Makio Saeki, Akira Yamaji, Sadaaki Maeda, & Kihachi Saito. (1996). Effect of morphine on secretion of amylase from isolated parotid acini. Life Sciences. 59(21). 1809–1819. 5 indexed citations
17.
Lameh, Jelveh, Ric I. Cone, Sadaaki Maeda, et al.. (1990). Structure and Function of G Protein Coupled Receptors. Pharmaceutical Research. 7(12). 1213–1221. 25 indexed citations
18.
Ohnishi, Tetsuo, Kihachi Saito, Sadaaki Maeda, et al.. (1990). Intracerebroventricular treatment of mice with pertussis toxin induces hyperalgesia and enhances 3H-nitrendipine binding to synaptic membranes: Similarity with morphine tolerance. Naunyn-Schmiedeberg s Archives of Pharmacology. 341-341(1-2). 123–7. 32 indexed citations
19.
Maeda, Sadaaki, Hiroyuki Ichikawa, Satoshi Wakisaka, Michio Akai, & Reizo Inoki. (1988). Occurrence of Methionine-Enkephalin-Like Immunoreactive Cells in the Feline Vagus Nerve. Cells Tissues Organs. 133(2). 127–129. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026